5 Pharmaceutical preparations and vaccines for the treatment of myocardial infarction, cancer, multiple sclerosis, stroke, sepsis, heredity deficiency of the molecule leading to increased thrombolytic events, and heparin resistance in medical procedures; biologics; cells, cell lines and cell cultures for medical and clinical use in the production of proteins for therapeutic and diagnostic use; proteins and cloned DNA from humans, plants, animals, bacteria and other micro-organisms for use as medical therapeutic reagents; transgenic and cloned animal products, namely, meat, tissue, cells or secretions for therapeutic and diagnostic use